This clinical trial will evaluate an investigational infant formula with an alternate source of DHA to determine if it provides normal growth and if it is well tolerated by term infants as compared to a marketed routine infant formula.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
QUADRUPLE
Enrollment
315
Birmingham Pediatric Associates
Birmingham, Alabama, United States
Body weight measured at each study visit
Time frame: 3.5 Months
Recall of infant formula intake at each study visit
Time frame: 3.5 months
Body length measured at each study visit
Time frame: 3.5 months
Recall of stool consistency measured at each study visit
Time frame: 3.5 months
Medically-confirmed adverse events collected throughout the study period
Time frame: 3.5 months
Head circumference measured at each study visit
Time frame: 3.5 months
Recall of gastrointestinal tolerance measured at each study visit
Time frame: 3.5 months
Blood Collection
Blood Collection from a subset of participants to measure levels of fatty acids such as docosahexaenoic acid (DHA) and arachidonic acid (ARA).
Time frame: Once at 120 days of age
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Greenvale Pediatrics - Hoover
Birmingham, Alabama, United States
Southeastern Pediatric Association
Dothan, Alabama, United States
Pediatrics East - Alabama Clinical Therapeutics
Pinson, Alabama, United States
Northwest Arkansas Pediatric Clinic
Fayetteville, Arkansas, United States
The Children's Clinic of Jonesboro, P.A.
Jonesboro, Arkansas, United States
Norwich Pediatric Group, PC
Norwich, Connecticut, United States
Children's Research, LLC
Altamonte Springs, Florida, United States
Physician Care Clinical Research
Sarasota, Florida, United States
Deaconess Clinical Research
Evansville, Indiana, United States
...and 12 more locations